![[current-page:title] logo](/sites/default/files/styles/logo/public/default_images/_no-logo.png?itok=8OH0tuUw){kind=logo}
Address
Technology Partners.
550 University Avenue
Palo Alto, CA 94301
United States
Phone
Email
Recent investment activity
KANDO id: 28603
Corporate information
Registration country
Company type
Venture capital firmFunds managed
| Fund | Type | Vintage | Currency | Committed capital |
|---|---|---|---|---|
| Technology Partners Fund VII LP | ||||
| Technology Partners Fund VI LP | ||||
| Technology Partners Fund V LP |
Funding rounds
Investment activity status
Active investor
Selected investments
Displaying 1 - 13 of 13| Company | Profile | Country | Date | Funding | ||
|---|---|---|---|---|---|---|
![[current-page:title] logo](/sites/default/files/styles/icon/public/default_images/_no-logo.png?itok=AH4pbDYM){kind=icon}
|
Benvenue Medical Inc | Engages in the design, manufacture, and marketing of medical devices for use in minimally invasive spinal therapies. | Series D | |||
|
|
Encirq Corp | Series A | ||||
|
|
Incline Therapeutics Inc | Patient controlled analgesia | Series A | |||
|
|
Iomai Corp | Biopharmaceutical company focused on discovering and developing vaccines and immune system stimulants. | Series C | |||
|
|
Revance Therapeutics Inc | Develops and commercializes therapeutic products for treating chronic disease and age-related changes to skin and soft tissue. | Venture | |||
|
|
Revance Therapeutics Inc | Develops and commercializes therapeutic products for treating chronic disease and age-related changes to skin and soft tissue. | Series D | |||
|
|
TRIA Beauty Inc | Venture | ||||
|
|
TRIA Beauty Inc | Series E | ||||
|
|
TRIA Beauty Inc | Series D | ||||
|
NanoGram Corp | Maker of core process technology for the manufacture of nanostructured materials for optical, electronic and energy applications | Venture led the round | |||
|
|
Rinat Neuroscience Corp | Discovers and commercializes novel antibody based drugs and drug targets for the major mental and neuro-degenerative diseases | Series B Follow-on investment | |||
|
|
Rinat Neuroscience Corp | Discovers and commercializes novel antibody based drugs and drug targets for the major mental and neuro-degenerative diseases | Series A Initial investment | |||
|
|
Visiogen Inc | A medical device company focused on dual-optic accommodating intraocular lens, called Synchrony, for the treatment of age-related vision loss. | Series D Initial investment |